CVC Capital Partners – The animal nutrition and health division of the DSM-Firmenich Group
The Acquisition is a private equity financial investment concerning the acquisition of DSM-Firmenich AG’s Animal Nutrition & Health business (the **Target**) by the following newly formed companies: 1. Specialty Bidco B.V.; 2. Specialty (U.S.) Bidco, Inc.; 3. Essential Bidco B.V.; and 4. Essential (U.S.) Bidco, Inc. These companies are all indirectly controlled by funds advised or managed by affiliates of CVC Capital Partners plc (**CVC Capital Partners**), a public limited company incorporated in Jersey and listed in Amsterdam. The CVC Network is a global alternative investment manager focused on private equity, credit, infrastructure and secondaries, and includes CVC Capital Partners, each of its subsidiaries, and the CVC Funds. The seller is DSM B.V., a private limited liability company incorporated in the Netherlands and part of DSM-Firmenich AG. The Target is a global provider of science-based animal nutrition and health solutions for livestock producers and feed manufacturers. Its global activities span: 1. vitamins and carotenoids; 2. premixes; 3. performance solutions; 4. aroma ingredients; and 5. precision services.
- Status
- Assessment completed
- ACCC determination
- Approved
- Stage
- Waiver application
- Notified
- 21 March 2026
- Determination published
- 7 April 2026
Acquirers
- Essential Bidco B.V.
- Specialty (U.S.) Bidco, Inc.
- Essential (U.S.) Bidco, Inc.
- Specialty Bidco B.V.
Targets
- SpecialtyCo US LLC
- Biomin Phytogenics GmbH (Germany)
- DSM Nutritional Products Holding AG (Switzerland)
- EssentialCo Holding AG
- Animal Nutrition & Health, LLC (US)
- DSM Nutritional Products GmbH
- DSM Nutritional Products Vietnam Ltd (Vietnam)
- DSM B.V.